Search Results - "Çiftçiler, Rafiye"

Refine Results
  1. 1

    COVID-19, Renin-Angiotensin System, and Hematopoiesis by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C.

    Published in Turkish journal of haematology (01-01-2020)
    “…We had initially indicated that there is a local hematopoietic bone marrow (BM) renin-angiotensin system (RAS), active in the physiological and pathological…”
    Get full text
    Journal Article
  2. 2

    Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma by Demiroğlu, Haluk, Çiftçiler, Rafiye, Büyükaşık, Yahya, Göker, Hakan

    Published in Turkish journal of haematology (01-01-2021)
    “…Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma…”
    Get full text
    Journal Article
  3. 3

    Ankaferd hemostat: from molecules to medicine by ÇİFTÇİLER, Rafiye, HAZNEDAROĞLU, İbrahim Celalettin

    Published in Turkish journal of medical sciences (03-11-2020)
    “…Ankaferd hemostat (ABS; Ankaferd Blood Stopper®, İstanbul, Turkey) is a hemostatic agent having an impact on red blood cell–fibrinogen interactions. The…”
    Get full text
    Journal Article
  4. 4

    A Systematic Review on Second Treatment-Free Remission (TFR) Attempt in Chronic Myeloid Leukemia (CML): Can it be Applied in Clinical Practice? by Çiftçiler, Rafiye, Akın, Mehmet G., Erat, Zeynep, Eşkazan, A. Emre

    Published in Clinical lymphoma, myeloma and leukemia (01-01-2023)
    “…The prognosis and life expectancy of chronic myeloid leukemia (CML) patients have improved significantly with the launch of first tyrosine kinase inhibitor…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Comprehensive Assessment of Common Medical Problems in Adult Patients with Hemophilia A: A Single-Center Experience in Turkey by Aydın,Mürüvvet Seda, Çiftçiler,Rafiye, İnkaya,Ahmet Çağkan, Aksu,Salih

    Published in Gazi tıp dergisi (01-01-2022)
    “…Objective: Chronic age related medical problems and blood-borne viral infections may be overlooked by the clinicians in Hemophilia A, and likewise Hemophilia A…”
    Get full text
    Journal Article
  7. 7

    Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to their Plasmacytoma Presentation at Diagnosis by Çiftçiler, Rafiye, Göker, Hakan, Demiroğlu, Haluk, Aksu, Salih, Sayınalp, Nilgun, Haznedaroğlu, İbrahim C., Malkan, Ümit Yavuz, Büyükaşık, Yahya, Özcebe, Osman

    Published in Turkish journal of haematology (01-01-2020)
    “…Multiple myeloma (MM) associated with extramedullary (EM) plasmacytoma has a poor therapeutic response and poor outcomes when treated with conventional…”
    Get full text
    Journal Article
  8. 8

    On Being a “Physician Patient” with His Own Experimental Therapeutic Drug by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C.

    Published in Turkish journal of haematology (2018)
    “…We have read with great interest the paper by Patıroğlu et al. [1] on the mucosal healing effects of Ankaferd BloodStopper (ABS), recently published in this…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effects of Smoking on Hematological Parameters and Ferritin Levels by Çiftçiler, Rafiye, Güven, Alper, Haznedaroğlu, İbrahim Celalettin, Aksu, Salih

    Published in Haseki tıp bülteni (01-12-2019)
    “…Aim: Cigarette smoking is associated with an increased risk of cardiovascular diseases, including coronary artery disease, peripheral vascular disease,…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet’s Disease by Ciftciler, Rafiye, Ciftciler, Erdinc, Haznedaroglu, Ibrahim

    Published in Archives of rheumatology (01-12-2019)
    “…Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes. In this article, we report a 50-year-old male patient who…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20